Skip to the page

Data / Drug companies / Folate Analog

Folate Analog drugs: 6 drugs from 32 companies in the FDA NDC directory

Folate Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 110 products in this class from 32 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 14, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 32Companies
  • 110Products
  • 6Drugs by generic name

Drugs in the Folate Analog class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Leucovorin calcium6218
Levoleucovorin75
Levoleucovorin injection42
Calcium folinate22
Folate, vitamin d312
Levoleucovorin calcium21

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
PureTek Corporation14tablet; tablet, chewableOther unapproved drugsAugust 21, 2026
Avion Pharmaceuticals, LLC8capsule, gelatin coated; tablet, coatedOther unapproved drugsJanuary 10, 2017
Meitheal Pharmaceuticals Inc.7injection, powder, lyophilized, for solution; injection, solutionGeneric drugs (ANDA)July 19, 2023
Slate Run Pharmaceuticals, LLC7injection, powder, lyophilized, for solution; injection, solutionGeneric drugs (ANDA)December 27, 2024
BluePoint Laboratories6injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 10, 2025
Hikma Pharmaceuticals USA Inc.6injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 7, 2016
Fresenius Kabi USA, LLC5injection, powder, lyophilized, for solution; injectionGeneric drugs (ANDA)July 27, 2018
Hikma Pharmaceuticals USA Inc.5tabletGeneric drugs (ANDA)February 22, 1993
Sagent Pharmaceuticals5injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 15, 2018
Carwin Pharmaceutical Associates, LLC4tablet, chewable; capsule, liquid filledOther unapproved drugsJune 1, 2015
Epic Pharma, LLC4tabletGeneric drugs (ANDA)January 1, 2021
Gland Pharma Limited4injection, powder, lyophilized, for solution; injectionGeneric drugs (ANDA)October 14, 2026
Ingenus Pharmaceuticals, LLC4tabletGeneric drugs (ANDA)July 30, 2020
Leading Pharma, LLC4tabletGeneric drugs (ANDA)November 16, 2020
Avyxa Pharma, LLC3injectionNew drug applications (NDA)March 16, 2026
Mylan Institutional LLC3injection, powder, lyophilized, for suspensionGeneric drugs (ANDA)July 23, 2019
Dr. Reddy's Laboratories Inc.2injection, solutionGeneric drugs (ANDA)September 26, 2018
Exeltis USA, Inc.2capsule, liquid filledOther unapproved drugsMarch 15, 2020
Hainan Poly Pharm. Co., Ltd.2injection, solutionGeneric drugs (ANDA)May 31, 2023
Jaymac Pharmaceuticals, LLC2capsule, delayed release pellets; capsuleOther unapproved drugsAugust 1, 2024
Teva Pharmaceuticals USA, Inc.2tabletGeneric drugs (ANDA)June 30, 1990
Acella Pharmaceuticals, LLC1tabletOther unapproved drugsMay 25, 2021
Acrotech Biopharma Inc1injection, powder, lyophilized, for solutionNew drug applications (NDA)January 2, 2019
American Health Packaging1tabletGeneric drugs (ANDA)February 17, 2017
Amneal Pharmaceuticals LLC1injection, solutionGeneric drugs (ANDA)September 8, 2017
Farmasierra Manufacturing SL1tabletUnapproved drugs for a shortageNovember 26, 2025
Glenmark Pharmaceuticals Inc., USA1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 12, 2025
Major Pharmaceuticals1tabletGeneric drugs (ANDA)March 27, 2026
Oncora Pharma, LLC1tablet, chewableOther unapproved drugsApril 7, 2026
Pfizer Laboratories Div Pfizer Inc1tabletUnapproved drugs for a shortageDecember 18, 2025
Proficient Rx LP1tabletGeneric drugs (ANDA)November 16, 2020
Skya Health, LLC1capsule, gelatin coatedOther unapproved drugsSeptember 4, 2026

Dosage forms

Dosage formProductsShare
Injection, powder, lyophilized, for solution3531.8%
Tablet3531.8%
Injection, solution87.3%
Tablet, chewable87.3%
Injection76.4%
Capsule, gelatin coated43.6%
Capsule43.6%
Injection, powder, lyophilized, for suspension32.7%
Capsule, liquid filled32.7%
Tablet, coated10.9%
Capsule, delayed release pellets10.9%
Tablet, film coated10.9%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.